Literature DB >> 15115866

Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

D L DeMeo1, V J Carey, H A Chapman, J J Reilly, L C Ginns, F E Speizer, S T Weiss, E K Silverman.   

Abstract

BACKGROUND: The Boston Early-Onset COPD study showed that current or ex-smoking first degree relatives of severe early onset COPD probands have significantly lower forced expiratory volume in 1 second (FEV(1)) and FEV(1)/forced vital capacity (FVC) values than current or ex-smoking control subjects, which suggests the existence of genetic risk factors for the development of COPD in response to cigarette smoking. We hypothesised that first degree relatives of early onset COPD probands may also have lower values of spirometric parameters such as forced expiratory flow at the mid-portion of forced vital capacity (FEF(25-75)) and FEF(25-75)/FVC.
METHODS: Using generalised estimating equations, FEF(25-75) and FEF(25-75)/FVC were analysed in 333 first degree relatives of probands with severe early onset COPD and 83 population based controls; analyses were also performed on data stratified by smoking status. Narrow sense heritability estimates were calculated using a variance component approach.
RESULTS: Significantly lower FEF(25-75) and FEF(25-75)/FVC were observed in smoking (FEF(25-75): beta -0.788 l/s (95% CI -1.118 to -0.457), FEF(25-75)/FVC: beta -20.4% (95% CI -29.3 to -11.6, p<0.0001 for both phenotypes) and non-smoking (FEF(25-75): beta -0.357 l/s (95% CI -0.673 to -0.041, p = 0.0271), FEF(25-75)/FVC: beta -9.5% (95% CI -17.1 to -1.9, p = 0.0145)) first degree relatives of early onset COPD probands. Narrow sense heritability estimates for FEF(25-75) (h(2) = 0.38) and FEF(25-75)/FVC (h(2) = 0.45) were similar to those for FEV(1) and FEV(1)/FVC.
CONCLUSION: Lower values of FEF(25-75) and FEF(25-75)/FVC in non-smoking first degree relatives of early onset COPD probands than in controls suggest a genetic susceptibility to develop obstructive lung disease, independent of smoking, which is magnified by exposure to deleterious environments as suggested by the further decrements in FEF(25-75) and FEF(25-75)/FVC seen in smoking first degree relatives. FEF(25-75) and FEF(25-75)/FVC have high heritability and are important intermediate phenotypes for inclusion in genetic epidemiological studies of COPD.

Entities:  

Mesh:

Year:  2004        PMID: 15115866      PMCID: PMC1747013          DOI: 10.1136/thx.2003.012856

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Familial prevalence of chronic obstructive pulmonary disease in a matched pair study.

Authors:  F Kueppers; R D Miller; H Gordon; N G Hepper; K Offord
Journal:  Am J Med       Date:  1977-09       Impact factor: 4.965

2.  Genetic and environmental determinants of chronic obstructive pulmonary disease.

Authors:  R K Larson; M L Barman; F Kueppers; H H Fudenberg
Journal:  Ann Intern Med       Date:  1970-05       Impact factor: 25.391

3.  Pulmonary function in identical twins: comparison of nonsmokers and smokers.

Authors:  P M Webster; E G Lorimer; S F Man; C R Woolf; N Zamel
Journal:  Am Rev Respir Dis       Date:  1979-02

4.  Risk factors in chronic obstructive pulmonary disease (COPD).

Authors:  B H Cohen; W C Ball; S Brashears; E L Diamond; P Kreiss; D A Levy; H A Menkes; S Permutt; M S Tockman
Journal:  Am J Epidemiol       Date:  1977-03       Impact factor: 4.897

5.  The relations between structural changes in small airways and pulmonary-function tests.

Authors:  M Cosio; H Ghezzo; J C Hogg; R Corbin; M Loveland; J Dosman; P T Macklem
Journal:  N Engl J Med       Date:  1978-06-08       Impact factor: 91.245

6.  A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations.

Authors:  B H Cohen; W C Ball; W B Bias; S Brashears; G A Chase; E L Diamond; S H Hsu; P Kreiss; D A Levy; H A Menkes; S Permutt; M S Tockman
Journal:  Johns Hopkins Med J       Date:  1975-09

7.  Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.

Authors:  E K Silverman; S T Weiss; J M Drazen; H A Chapman; V Carey; E J Campbell; P Denish; R A Silverman; J C Celedon; J J Reilly; L C Ginns; F E Speizer
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

8.  Household aggregation of pulmonary function and chronic bronchitis.

Authors:  I B Tager; B Rosner; P V Tishler; F E Speizer; E H Kass
Journal:  Am Rev Respir Dis       Date:  1976-09

9.  Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity.

Authors:  J Mead
Journal:  Am Rev Respir Dis       Date:  1980-02

10.  Functional correlations with mild and moderate emphysema in excised human lungs.

Authors:  T L Petty; G W Silvers; R E Stanford
Journal:  Am Rev Respir Dis       Date:  1981-12
View more
  23 in total

1.  Change in pulmonary function in chronic obstructive pulmonary disease stage 0 patients.

Authors:  Su-Gang Gong; Wen-Lan Yang; Jin-Ming Liu; Wen-Zeng Liu; Wei Zheng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.

Authors:  Jason W Chien; Lue Ping Zhao; John A Hansen; Wen Hong Fan; Tanyalak Parimon; Joan G Clark
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

3.  Modelling the dynamics of expiratory airflow to describe chronic obstructive pulmonary disease.

Authors:  Marko Topalovic; Vasileios Exadaktylos; Marc Decramer; Thierry Troosters; Daniel Berckmans; Wim Janssens
Journal:  Med Biol Eng Comput       Date:  2014-09-30       Impact factor: 2.602

4.  Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.

Authors:  Moumita Ghosh; York E Miller; Ichiro Nakachi; Jennifer B Kwon; Anna E Barón; Alexandra E Brantley; Daniel T Merrick; Wilbur A Franklin; Robert L Keith; R William Vandivier
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

5.  Genetic and environmental influence on lung function impairment in Swedish twins.

Authors:  Jenny Hallberg; Anastasia Iliadou; Martin Anderson; Maria Gerhardsson de Verdier; Ulf Nihlén; Magnus Dahlbäck; Nancy L Pedersen; Tim Higenbottam; Magnus Svartengren
Journal:  Respir Res       Date:  2010-07-06

6.  Respiratory symptoms following wildfire smoke exposure: airway size as a susceptibility factor.

Authors:  Maria C Mirabelli; Nino Künzli; Edward Avol; Frank D Gilliland; W James Gauderman; Rob McConnell; John M Peters
Journal:  Epidemiology       Date:  2009-05       Impact factor: 4.822

7.  Network medicine analysis of COPD multimorbidities.

Authors:  Solène Grosdidier; Antoni Ferrer; Rosa Faner; Janet Piñero; Josep Roca; Borja Cosío; Alvar Agustí; Joaquim Gea; Ferran Sanz; Laura I Furlong
Journal:  Respir Res       Date:  2014-09-24

8.  Sex-specific features of emphysema among current and former smokers with COPD.

Authors:  Megan Hardin; Marilyn Foreman; Mark T Dransfield; Nadia Hansel; MeiLan K Han; Michael H Cho; Surya P Bhatt; Joe Ramsdell; David Lynch; Jeffrey L Curtis; Edwin K Silverman; George Washko; Dawn DeMeo
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

9.  Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers.

Authors:  Jin J Zhou; Michael H Cho; Peter J Castaldi; Craig P Hersh; Edwin K Silverman; Nan M Laird
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

10.  Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study.

Authors:  Marilyn G Foreman; Lening Zhang; James Murphy; Nadia N Hansel; Barry Make; John E Hokanson; George Washko; Elizabeth A Regan; James D Crapo; Edwin K Silverman; Dawn L DeMeo
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.